LPL Financial’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $520K | Buy |
16,482
+429
| +3% | +$13.5K | ﹤0.01% | 4285 |
|
|
2025
Q1 | $526K | Buy |
16,053
+3,312
| +26% | +$108K | ﹤0.01% | 4070 |
|
|
2024
Q4 | $461K | Buy |
12,741
+2,029
| +19% | +$73.4K | ﹤0.01% | 4101 |
|
|
2024
Q3 | $334K | Buy |
10,712
+552
| +5% | +$17.2K | ﹤0.01% | 4257 |
|
|
2024
Q2 | $272K | Buy |
10,160
+2,739
| +37% | +$73.3K | ﹤0.01% | 4272 |
|
|
2024
Q1 | $253K | Buy |
+7,421
| New | +$253K | ﹤0.01% | 4271 |
|
|
2023
Q3 | – | Sell |
-7,406
| Closed | -$223K | – | 4715 |
|
|
2023
Q2 | $223K | Sell |
7,406
-1,253
| -14% | -$37.7K | ﹤0.01% | 4028 |
|
|
2023
Q1 | $314K | Sell |
8,659
-795
| -8% | -$28.8K | ﹤0.01% | 3682 |
|
|
2022
Q4 | $337K | Sell |
9,454
-9,474
| -50% | -$338K | ﹤0.01% | 3546 |
|
|
2022
Q3 | $641K | Sell |
18,928
-4,591
| -20% | -$155K | ﹤0.01% | 2910 |
|
|
2022
Q2 | $680K | Buy |
23,519
+1,883
| +9% | +$54.4K | ﹤0.01% | 2908 |
|
|
2022
Q1 | $699K | Buy |
21,636
+64
| +0.3% | +$2.07K | ﹤0.01% | 2909 |
|
|
2021
Q4 | $629K | Buy |
21,572
+1,754
| +9% | +$51.1K | ﹤0.01% | 3068 |
|
|
2021
Q3 | $529K | Buy |
19,818
+1,370
| +7% | +$36.6K | ﹤0.01% | 3153 |
|
|
2021
Q2 | $568K | Sell |
18,448
-2,371
| -11% | -$73K | ﹤0.01% | 3045 |
|
|
2021
Q1 | $545K | Buy |
20,819
+3,874
| +23% | +$101K | ﹤0.01% | 2939 |
|
|
2020
Q4 | $426K | Buy |
16,945
+1,192
| +8% | +$30K | ﹤0.01% | 2895 |
|
|
2020
Q3 | $328K | Sell |
15,753
-127
| -0.8% | -$2.64K | ﹤0.01% | 2822 |
|
|
2020
Q2 | $377K | Buy |
15,880
+712
| +5% | +$16.9K | ﹤0.01% | 2636 |
|
|
2020
Q1 | $273K | Sell |
15,168
-403
| -3% | -$7.25K | ﹤0.01% | 2561 |
|
|
2019
Q4 | $369K | Sell |
15,571
-98
| -0.6% | -$2.32K | ﹤0.01% | 2609 |
|
|
2019
Q3 | $431K | Sell |
15,669
-128
| -0.8% | -$3.52K | ﹤0.01% | 2376 |
|
|
2019
Q2 | $523K | Sell |
15,797
-8,747
| -36% | -$290K | ﹤0.01% | 2240 |
|
|
2019
Q1 | $860K | Sell |
24,544
-2,850
| -10% | -$99.9K | ﹤0.01% | 1750 |
|
|
2018
Q4 | $910K | Buy |
27,394
+1,739
| +7% | +$57.8K | ﹤0.01% | 1591 |
|
|
2018
Q3 | $1.29M | Sell |
25,655
-18,800
| -42% | -$947K | ﹤0.01% | 1474 |
|
|
2018
Q2 | $2.66M | Buy |
44,455
+24,437
| +122% | +$1.46M | 0.01% | 970 |
|
|
2018
Q1 | $917K | Sell |
20,018
-1,109
| -5% | -$50.8K | ﹤0.01% | 1659 |
|
|
2017
Q4 | $842K | Sell |
21,127
-1,325
| -6% | -$52.8K | ﹤0.01% | 1646 |
|
|
2017
Q3 | $898K | Buy |
22,452
+2,298
| +11% | +$91.9K | ﹤0.01% | 1514 |
|
|
2017
Q2 | $869K | Buy |
20,154
+364
| +2% | +$15.7K | ﹤0.01% | 1460 |
|
|
2017
Q1 | $618K | Sell |
19,790
-4,423
| -18% | -$138K | ﹤0.01% | 1615 |
|
|
2016
Q4 | $628K | Sell |
24,213
-16,177
| -40% | -$420K | ﹤0.01% | 1539 |
|
|
2016
Q3 | $950K | Sell |
40,390
-1,585
| -4% | -$37.3K | 0.01% | 1235 |
|
|
2016
Q2 | $905K | Sell |
41,975
-16,536
| -28% | -$357K | 0.01% | 1239 |
|
|
2016
Q1 | $946K | Buy |
58,511
+20,025
| +52% | +$324K | ﹤0.01% | 1712 |
|
|
2015
Q4 | $517K | Buy |
38,486
+9,879
| +35% | +$133K | ﹤0.01% | 2164 |
|
|
2015
Q3 | $429K | Buy |
+28,607
| New | +$429K | ﹤0.01% | 1921 |
|